Centre Hospitalier Regional Universitaire De Tours

At Centre Hospitalier Regional Universitaire De Tours, clinical trials in skin and connective tissue diseases and immune system diseases focus on conditions such as alopecia areata and atopic dermatitis. These studies are designed to evaluate new treatment options and better understand how to improve symptom control in children, adolescents, and adults.

• Testing targeted therapies for alopecia areata in pediatric patients
• Evaluating treatment effectiveness for atopic dermatitis with added topical care
• Assessing safety and long-term benefit of newer immune-based treatments

This area of research reflects a strong interest in finding more effective and better-tolerated approaches for chronic inflammatory skin conditions.

The site also supports trials in digestive system and oral physiological phenomena and immune system processes, with a particular emphasis on Crohn's disease. Research here aims to improve treatment response in children with moderate to severe disease and to expand options for patients who have not responded well to standard therapies.

• Studying a new therapy for pediatric Crohn's disease
• Measuring effectiveness in children with active inflammatory bowel disease
• Evaluating safety and real-world usefulness of advanced immune treatments

These trials highlight the hospital’s role in advancing care for complex childhood digestive disorders.

Clinical research in neoplasms and hemic and lymphatic diseases includes studies for standard risk ALK-positive anaplastic large cell lymphoma. The goal is to improve cure rates and support more effective treatment strategies for children and adolescents with this rare cancer.

• Evaluating treatment effectiveness in ALK-positive anaplastic large cell lymphoma
• Seeking better outcomes for children with a lymphatic malignancy
• Exploring ways to increase long-term disease control

This research area shows a clear commitment to pediatric cancer care and to refining therapies for rare blood-related cancers.

Another important field at the Hôpital Clocheville department involves female urogenital diseases and pregnancy complications alongside immune-related disease processes, with trials focused on lymphatic malformations associated with PIK3CA mutation. The main purpose is to assess whether targeted treatment can reduce these abnormalities and improve patient outcomes.

• Testing a targeted therapy for PIK3CA-related lymphatic malformations
• Evaluating radiological response as a marker of improvement
• Supporting care for children and adults with rare vascular-lymphatic conditions

These studies contribute to better diagnosis and treatment planning for uncommon disorders that often require specialized expertise.